English
Español
☰
About ObsITI
At a glance
Immune Tolerance Induction (ITI)
Patient inclusion and exclusion criteria
Current status
Success criteria
Satellite Studies
Product / batch selection for individualised ITI
Thrombin Generation Test (TGT) to monitor the haemostatic efficacy of FVIII
F8
gene analysis / Immunogenotyping / HLA genotyping
Thrombin generation assay (TGA)
Immune-monitoring of patients undergoing ITI
Epitope mapping / IgG isotyping
Inhibitor Binding Affnity (IBA)
Who we are
Principle investigator and Study co-ordinator
Co-investigators
Scientific ObsITI board / DMC
How to join the study
Current news
News
Publications
International open-label, uncontrolled, non-interventional, multi-centre observational program conducted by the HZRM, Frankfurt-Mörfelden, Germany
To be enrolled in the study, patients have to fulfill inclusion criteria
The ObsITI study is conducted by the experienced Haemophilia Center Rhine-Main (HZRM)
Scientists with international recognition evaluate and document data from patients on the success of ITI.
7 optional satellite studies will allow the investigators to correlate the individual success of ITI and to individualize the ITI treatment.
Auf dieser Seite wurde noch kein Inhalt hinterlegt. (Seite ID 1)